EMBC

Conviction 49HealthcareScan · Thu, Sep 24, 2026

Embecta Corp. (EMBC) closed at $5.63 (+0.90%) on Sep 24, 2026. Price is above its 50-day and below its 200-day moving average. RSI(14) 64, RS Rating 87, -61.7% from its 52-week high, -51.7% year to date. Sector: Healthcare · SURGICAL & MEDICAL INSTRUMENTS & APPARATUS.

EMBC$5.63+0.90%

ResistanceSupportVol 14Insider buy

Vol MA14 1.16M

Jun 26Jul 15Aug 3Aug 19Sep 8Sep 24

Embecta Corp.SURGICAL & MEDICAL INSTRUMENTS & APPARATUSwww.embecta.com ↗

Price5.63

Change+0.90%

Gap+1.08%

Rel volume0.86×

Avg volume1.3M

Avg $ vol6.86M

SMA 205.31

SMA 504.65

SMA 2007.20

Price vs 50+21.06%

Price vs 200-21.75%

MA stackmixed

50/200 cross—

Supertrendup · 4.87

RSI (14)64

MACD hist-0.00

MACD cross—

Stoch %K / %D73 / 70

ADX (14)28

+DI / −DI30 / 17

RSI divergence—

MACD divergence—

ATR %4.52%

ADR %4.69%

52w high14.71

52w low2.90

From 52w high-61.73%

Above 52w low+94.14%

New 52w highNo

SqueezeOff

Bollinger width20.68%

%B0.79

Donchian pos74.77%

Donchian high5.91

Donchian low4.80

AVWAP (52w high)5.84

vs AVWAP high-3.63%

AVWAP (52w low)3.90

vs AVWAP low+44.29%

OBV trendUp

Chaikin MF (20)0.24

Today vs 20d0.86×

Avg vol (14d)1.16M

Avg vol (20d)1.3M

Avg $ vol (20d)6.86M

Market cap318.99M

RS Rating87 / 99

RS 3m (vs SPY)+76.54%

RS 6m (vs SPY)-54.26%

RS line new highNo

Trend template3/8

Technical rank45.5

1 week+8.48%

1 month+11.93%

3 months+81.03%

6 months-37.44%

1 year-61.36%

YTD-51.72%

P/E3.34

P/B-0.52

P/S0.30

P/FCF1.75

EPS1.62

Div yield10.97%

ROE-15.57%

ROA7.54%

Debt/Eq-2.37

Current1.68

EV/EBITDA5.51

Gross margin62.64%

Net margin8.83%

Rev growth-3.80%

EPS growth21.84%

Price target—

Target upside—

Analyst rating—

Institutional97.87%

Ent. value1.56B

Revenue271.7M

Net income21.1M

Gross profit153.3M

Free cash flow182.4M

IndustrySURGICAL & MEDICAL INSTRUMENTS & APPARATUS

ExchangeNasdaq

Shares out59.33M

Employees1.85K

ListedMon, Mar 21, 2022

Free float58.59M

Float %98.8%

Short interest6.27M

Days to cover4.6d

Short volume64.5%

Squeeze score61 / 100

Next earnings—

EPS forecast—

Last EPS vs est$0.56 vs $0.26

Last surprise+115.4% beat

Setup gradeC

Conviction49 / 100

Pattern quality—

Tech rank45.5 / 100

Group rank59 / 100

Status laneNo active setup

Setup direction—

Pattern family

Resistance5.77

Support4.14

Days since event—

Candle confirm—

Financials as of Tue, Jun 30, 2026 · quarterly.

Congress activity

Disclosed STOCK Act trades in EMBC

All disclosures →

No recent disclosed trades by Congress in EMBC. STOCK Act filings can lag the trade by up to 45 days.

Insider activity

SEC Form 4 transactions in EMBC · open-market 4 buys

Insider	Side	Shares	Value	Traded	Filed
Elguicze Jacob SVP and CFO · Common Stock · 2026-08-12	Buy	20K	$93K	2026-08-12	2026-08-13
HOMBACH ROBERT J. Director · Common Stock · 2026-08-12	Buy	45K	$224K	2026-08-12	2026-08-13
Mann Jeffrey Z Pres, Pharm Svc&Prod Mgmt, CLO · Common Stock · 2026-08-12	Buy	20K	$100K	2026-08-12	2026-08-13
Kurdikar Devdatt President and CEO · Common Stock · 2026-08-12	Buy	30K	$141K	2026-08-12	2026-08-13
Casner Jean Chief Human Resources Officer · Common Stock · 2026-08-09	Tax	1.48K	$7K	2026-08-09	2026-08-11
Roth Anthony M. VP, Chief Accounting Officer · Common Stock · 2026-06-01	Grant	30K	$0	2026-06-01	2026-06-02

SEC filings

EDGAR filings in EMBC · 6 recent

EDGAR →

Get daily signals & real-time alerts.

StockSetups scans ~12,300 US stocks & ETFs after every close and sorts every long setup into four ranked lanes — each with a trade plan — plus an always-on engine firing 35+ real-time intraday alerts. Free for 14 days, cancel in one click.

Start free — 14-day full access →

Educational data, not financial advice. Patterns, levels and the trade plan are algorithmic, not a recommendation to trade.